Market insight in association with

New wearable MRI scanner could read your mind

A new wearable device could revolutionise the diagnosis of brain tumours and heart disease, with the potential to ‘read’ patients’ thoughts.


The prototype, developed by San Francisco-based start-up Openwater, can scan the brain and body with a resolution a billion times higher than that of a traditional MRI (magnetic resonance imaging) device.


By using opto-electronics, the wearable scanner could replace the functionality of bulky MRI machines and enable constant monitoring, aiding the treatment of cancer, cardiovascular diseases, internal bleeding, mental diseases and neurodegenerative diseases.


The device is designed to be worn inside a ski-hat or similar piece of clothing, and uses infrared light to scan the brain or body in minute detail. The image is then relayed back to a display screen, shrinking the pixels on display to almost the wavelength of light.


Tumours and clogged arteries can be detected by scanning the surrounding blood flow, and Openwater’s goal is to have the device track the flow of oxygenated blood to different parts of the brain and effectively ‘read’ thoughts.

"A thousand times cheaper" than MRI

While the technology that powers this device is currently available, it is limited by the cost and size of the equipment. Openwater’s device is not only smaller, but also much more affordable than current MRI machines.


“It is a thousand times cheaper than an MRI machine and a billion times higher resolution,” Openwater founder Mary Lou Jepse told the Financial Times in February. “That’s a lot of zeros.”


Once developed, the wearable MRI scanner will have the capability to receive clear images based on blood-flow in the brain, which could allow a person to upload their thoughts directly to a computer.


This technology opens up debate about the ethical implications of mind-reading, however. Jepsen has previously discussed whether a subject’s thoughts could be deleted once shared, and the device would have to be approved by the government before commercial use.


Openwater plans to release a very limited number of prototypes to early access partners next year.

Share this article

Go to article: Home | Regulation: ready for the digital age?Go to article: In this issueGo to article: TelemedGo to article: Telemed Company InsightGo to article: ContentsGo to article: ARPAGo to article: NewsGo to article: Tricor SystemsGo to article: Will automation take over healthcare jobs? Industry experts share their opinionGo to article: MikronGo to article: Is regulation ready for the rise of digital health products?Go to article: Scandinavian Health Ltd Company insightGo to article: Scandinavian Health LtdGo to article: Laboratory-developed tests are under the regulatory spotlightGo to article: Micro Systems Technologies Management AGGo to article: 23andMe's at-home genetic test is now approved for breast cancerGo to article: Art of TechnologyGo to article: FDA approves first AI device to detect diabetic retinopathyGo to article: BISAGo to article: New wearable MRI scanner could read your mindGo to article: Frankfurt Laser CompanyGo to article: Frankfurt Laser Company | Company InsightGo to article: Rising number of surgical procedures to drive sutures market to $4.5bn by 2024Go to article: FormacoatGo to article: Formacoat Company InsightGo to article: Med Tech trade post-Brexit: it's time to take actionGo to article: MPS Microsystems Go to article: MPS Microsystems Company InsightGo to article: Inside the UK's new healthcare photonics centreGo to article: raPHARMGo to article: Virtual surgery: the healthcare potential of augmented realityGo to article: Alpha TechnicsGo to article: Upcoming events for the medical devices industryGo to article: AerotechGo to article: Event: AchemaGo to article: Nelson LabGo to article: Event: EPHJ-EPMT-SMTGo to article: AccumoldGo to article: Next issue previewGo to article: Maraca International